We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Moves -1.34%: What You Should Know
Read MoreHide Full Article
In the latest market close, Oscar Health, Inc. (OSCR - Free Report) reached $13.30, with a -1.34% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 1.97%. Meanwhile, the Dow lost 1.69%, and the Nasdaq, a tech-heavy index, lost 2.7%.
The company's shares have seen a decrease of 8.86% over the last month, not keeping up with the Finance sector's loss of 0.82% and the S&P 500's loss of 2.79%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. On that day, Oscar Health, Inc. is projected to report earnings of $0.83 per share, which would represent year-over-year growth of 33.87%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.8 billion, up 30.75% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.69 per share and a revenue of $11.04 billion, indicating changes of +590% and +20.34%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 19.54 right now. This signifies a premium in comparison to the average Forward P/E of 10.4 for its industry.
The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 42, putting it in the top 17% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Moves -1.34%: What You Should Know
In the latest market close, Oscar Health, Inc. (OSCR - Free Report) reached $13.30, with a -1.34% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 1.97%. Meanwhile, the Dow lost 1.69%, and the Nasdaq, a tech-heavy index, lost 2.7%.
The company's shares have seen a decrease of 8.86% over the last month, not keeping up with the Finance sector's loss of 0.82% and the S&P 500's loss of 2.79%.
The investment community will be paying close attention to the earnings performance of Oscar Health, Inc. in its upcoming release. On that day, Oscar Health, Inc. is projected to report earnings of $0.83 per share, which would represent year-over-year growth of 33.87%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.8 billion, up 30.75% from the year-ago period.
In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of $0.69 per share and a revenue of $11.04 billion, indicating changes of +590% and +20.34%, respectively, from the former year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. At present, Oscar Health, Inc. boasts a Zacks Rank of #3 (Hold).
Valuation is also important, so investors should note that Oscar Health, Inc. has a Forward P/E ratio of 19.54 right now. This signifies a premium in comparison to the average Forward P/E of 10.4 for its industry.
The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 42, putting it in the top 17% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.